What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

1. Writers and readers of sialylation in immunoregulation in cancer.The Journal of biological chemistry · 2026
   Review
2. Chemoenzymatically Synthesized O-Acetylated GD3 Gangliosides to Examine Viral Receptor Specificities in a Cellular Context.Angewandte Chemie (International ed. in English) · 2026
   Article
3. The bioactive sphingolipid playbook. A primer for the uninitiated as well as sphingolipidologists.Journal of lipid research · 2025
   Review
4. Insights into Siglec-7 Binding to Gangliosides: NMR Protein Assignment and the Impact of Ligand Flexibility.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
   Article
5. NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon.Nature communications · 2025
   Article
6. The physiological characteristics and applications of sialic acid.NPJ science of food · 2025
   Review
7. Don't Be Surprised When These Surprise You: Some Infrequently Studied Sphingoid Bases, Metabolites, and Factors That Should Be Kept in Mind During Sphingolipidomic Studies.International journal of molecular sciences · 2025
   Review
8. Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases.International journal of molecular sciences · 2024
   Review
9. Establishment of a targeted analysis method for gangliosides in mouse tissues by HILIC-ESI-MS/MS.Analytical and bioanalytical chemistry · 2024
   Article
10. Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers.International journal of molecular sciences · 2024
    Review
11. Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment.Cancer metastasis reviews · 2023
    Review
12. Chemoenzymatic Synthesis ofTetrahedron · 2023
    Article
13. Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy.Frontiers in pharmacology · 2023
    Review
14. The biological role and immunotherapy of gangliosides and GD3 synthase in cancers.Frontiers in cell and developmental biology · 2023
    Review
15. Lipid metabolism in pancreatic cancer: emerging roles and potential targets.Cancer communications (London, England) · 2022
    Review
16. Aberrant Sialylation in Cancer: Therapeutic Opportunities.Cancers · 2022
    Review
17. Sulfation of sialic acid is ubiquitous and essential for vertebrate development.Scientific reports · 2022
    Article
18. Role of GD3 Synthase ST8Sia I in Cancers.Cancers · 2022
    Review
19. Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma.Biomolecules · 2022
    Review
20. Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas?Journal of applied biomedicine · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as